Nokea
What is a type of medication that helps to prevent blood clots by thinning the blood?
- A. Anticoagulant
- B. Beta-blocker
- C. ACE inhibitor
- D. Calcium channel blocker
Correct Answer: A
Rationale: The correct answer is A: Anticoagulant. Anticoagulants prevent blood clots by inhibiting the blood's ability to clot. They do not actually thin the blood, but rather prevent clots from forming. Beta-blockers (B), ACE inhibitors (C), and Calcium channel blockers (D) are not used to prevent blood clots. Beta-blockers are used to treat high blood pressure and heart conditions, ACE inhibitors are used to treat high blood pressure and heart failure, and Calcium channel blockers are used to treat high blood pressure and certain heart conditions.
You may also like to solve these questions
The client on furosemide (Lasix) has a potassium level of 3.1 mEq/L. What is the nurse's priority action?
- A. Administer a potassium supplement.
- B. Hold the furosemide and notify the healthcare provider.
- C. Continue the current dose of furosemide.
- D. Administer Digibind.
Correct Answer: A
Rationale: The correct answer is A because a potassium level of 3.1 mEq/L indicates hypokalemia, a common side effect of furosemide. Administering a potassium supplement is essential to prevent complications like cardiac dysrhythmias. Choice B is incorrect because holding furosemide can worsen the client's condition. Choice C is incorrect as continuing the current dose can further lower potassium levels. Choice D is incorrect as Digibind is used to treat digoxin toxicity, not hypokalemia. Administering a potassium supplement addresses the underlying issue.
Which of the following structures of the heart is called the pacemaker of the heart?
- A. AV junction
- B. SA node
- C. AV node
- D. Purkinje fibers
Correct Answer: B
Rationale: The sinoatrial (SA) node initiates and regulates the heartbeat, acting as the heart's natural pacemaker.
Priority Decision: While teaching women about the risks and incidence of CAD, what does the nurse emphasize?
- A. Smoking is not as significant a risk factor for CAD in women as it is in men
- B. Women seek treatment sooner than men when they have symptoms of CAD
- C. Estrogen replacement therapy in postmenopausal women decreases the risk for CAD
- D. CAD is the leading cause of death in women, with a higher mortality rate after MI than in men
Correct Answer: D
Rationale: CAD is a major cause of mortality in women.
Which of the following is a central vasoconstrictor and peripheral vasodilator?
- A. Parasympathetic nervous system
- B. Sympathetic nervous system
- C. Dopamine
- D. Epinephrine
Correct Answer: D
Rationale: The correct answer is D: Epinephrine. Epinephrine acts as a central vasoconstrictor by constricting blood vessels in vital organs to redirect blood flow to muscles during fight-or-flight response. It also acts as a peripheral vasodilator by dilating blood vessels in skeletal muscles to increase oxygen delivery. Parasympathetic nervous system (A) mainly promotes relaxation, sympathetic nervous system (B) typically causes vasoconstriction, and dopamine (C) has limited vasoactive effects.
The healthcare provider is preparing to administer heparin to a client. What lab value should be monitored?
- A. PT/INR
- B. aPTT
- C. Platelet count
- D. Hemoglobin
Correct Answer: B
Rationale: The correct lab value to monitor when administering heparin is aPTT (Activated Partial Thromboplastin Time). This is because heparin affects the intrinsic pathway of the clotting cascade, which is reflected in the aPTT value. Monitoring aPTT helps ensure the therapeutic range of heparin to prevent clotting complications. PT/INR and platelet count are not specific to heparin monitoring, and hemoglobin does not directly reflect heparin's anticoagulant effects.